With the Inclusion of microbiome modulators in human health, precision medicine has evolved toward being a more personalized and integrative approach. Despite limited exposure, the Global Human Microbiome Modulators Market has witnessed a steady growth at a CAGR of 6.08% during the period, 2015-2017. Initially, microbiome modulators were employed only during the treatment of digestive complications. However, at present clinical trials are ongoing for a range of diseases indications. The market is further expected to grow owing to the development of drugs that can help modulate the microbiomes.